Albers Jeffrey W.
All 5 shown
- Spyre Therapeutics, Inc. Director5,000 sharesOption exercise
- Spyre Therapeutics, Inc. Director$1,046,800Open-market sale
- Spyre Therapeutics, Inc. Director$835,040Open-market sale
- Spyre Therapeutics, Inc. Director$522,350Open-market sale
- Spyre Therapeutics, Inc. Director$51,950Option exercise